Sheila Frame new President for the Americas at Amryt
Biopharmaceutical company Amryt have appointed Sheila Frame as President for the Americas.
Frame has previously held senior leadership roles across several specialty areas with Novartis, Bristol-Myers Squibb, UCB, and AstraZeneca, and has worked and lived in North America and in Europe. She holds an MBA from Concordia University.
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing, and commercialising innovative treatments to help improve the lives of patients with rare and orphan diseases.
Dr Joe Wiley, CEO of Amryt Pharma, said: “Sheila is a very experienced biotech executive and brings a track record of success in commercialising products and leading commercial teams to Amryt. I really look forward to working with Sheila and I know she will play an important role in ensuring our innovative therapies reach patients in need.”
Frame commented: “I have admired Amryt for some time and I’m really excited to join the team at such a pivotal point in Amryt’s development.”